{
  "zip": "4070",
  "sector": "Healthcare",
  "fullTimeEmployees": 97735,
  "longBusinessSummary": "Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Further, the company discovers, develops, and delivers gene therapies. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19; collaboration and license agreement with Lead Pharma Holding B.V. to develop oral small molecules to treat a range of immune mediated diseases; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company was founded in 1896 and is headquartered in Basel, Switzerland.",
  "city": "Basel",
  "phone": "41 61 688 11 11",
  "country": "Switzerland",
  "companyOfficers": [],
  "website": "http://www.roche.com",
  "maxAge": 1,
  "address1": "Konzern Hauptsitz",
  "fax": "41 61 691 00 14",
  "industry": "Drug Manufacturersâ€”General",
  "address2": "Grenzacherstrasse 124",
  "previousClose": 349.8,
  "regularMarketOpen": 352.5,
  "twoHundredDayAverage": 346.2031,
  "trailingAnnualDividendYield": 0.023942253,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 359,
  "navPrice": null,
  "averageDailyVolume10Day": 6400,
  "totalAssets": null,
  "regularMarketPreviousClose": 349.8,
  "fiftyDayAverage": 342.79727,
  "trailingAnnualDividendRate": 8.375,
  "open": 352.5,
  "averageVolume10days": 6400,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": 1551916800,
  "beta": 0.240551,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 351.5,
  "priceHint": 2,
  "currency": "USD",
  "trailingPE": 28.619934,
  "regularMarketVolume": 5467,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 303095119872,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 4888,
  "priceToSalesTrailing12Months": null,
  "dayLow": 351.5,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 5467,
  "fiftyTwoWeekHigh": 399,
  "forwardPE": 21.239277,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 281.04,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 359,
  "exchange": "PNK",
  "shortName": "ROCHE HOLDINGS AG",
  "longName": "Roche Holding AG",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": true,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RHHVF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_687140",
  "uuid": "17bdab1b-4c88-394f-a8bb-e2385d85e7a1",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.20772,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": 16.55,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 694641984,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 32.307,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.36778,
  "netIncomeToCommon": null,
  "trailingEps": 12.282,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 10.880305,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 720642339,
  "enterpriseValue": 298953637888,
  "threeYearAverageReturn": null,
  "lastSplitDate": 988934400,
  "lastSplitFactor": "100:1",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": -0.063,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 352.5,
  "logo_url": "https://logo.clearbit.com/roche.com"
}